Spyre Therapeutics, Inc. SYRE Debt-to-assets
Debt-to-assets at other companies
Other financials
Where this comes from
Calculated from Spyre Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Spyre Therapeutics, Inc.’s 10-Q, filed August 7, 2024, on SEC EDGAR. View the filing →
Ask your AI about Spyre Therapeutics, Inc.'s debt-to-assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Spyre Therapeutics, Inc.'s debt-to-assets?
- Spyre Therapeutics, Inc. (SYRE) reported debt-to-assets of 0× in Q2 2023.
- How has Spyre Therapeutics, Inc.'s debt-to-assets changed year-over-year?
- Spyre Therapeutics, Inc.'s debt-to-assets decreased by 60.4% year-over-year, from 0× to 0×.
- What is the long-term trend for Spyre Therapeutics, Inc.'s debt-to-assets?
- Over 2 years (2020 to 2022), Spyre Therapeutics, Inc.'s debt-to-assets has grown at a 38.2% compound annual growth rate (CAGR), from 0× to 0.1×.
- What does debt-to-assets mean?
- Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.